Daniel Laajala
teelaa@utu.fi +358 29 450 3805 Vesilinnantie 5 Turku |
- (2026)
- European Urology Oncology
- (2025)
- BJUI COMPASS
- (2024)
- Journal of Translational Medicine
- NPEPPS Is a Druggable Driver of Platinum Resistance (2024)
- Cancer Research
- (2024)
- Frontiers in PharmacologyBMC Women's Health
- A harmonized resource of integrated prostate cancer clinical, -omic, and signature features (2023)
- Scientific Data
- 2023
- Clinical Lung CancerScience Translational Medicine
- Female doping: observations from a data lake study in the Hospital District of Helsinki and Uusimaa, Finland (2023)
- Microbiome-based risk prediction in incident heart failure: a community challenge (2023) Erawijantari PP, Kartal E, Liñares-Blanco J, Laajala TD, Feldman LE, Carmona-Saez P, Shigdel R, Claesson MJ, Bertelsen RJ, Gomez-Cabrero D, Minot S, Albrecht J, Chung V, Inouye M, Jousilahti P, Schultz JH, Friederich HC, Knight R, Salomaa V, Niiranen T, Havulinna AS, Saez-Rodriguez J, Levinson RT, Lahti L; FINRISK Microbiome DREAM Challenge and ML4 Microbiome Communities
- Non-muscle-invasive bladder cancer molecular subtypes predict differential response to intravesical Bacillus Calmette-Guérin (2023)



